dihydroergotamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Etienne, N; Guesnier, L; Hickel, P; Maroteaux, L; Schaerlinger, B | 1 |
1 other study(ies) available for dihydroergotamine and 4-iodo-2,5-dimethoxyphenylisopropylamine
Article | Year |
---|---|
Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.
Topics: Amphetamines; Animals; Binding, Competitive; Cell Line; Cyclic GMP; Dihydroergotamine; Humans; Inositol Phosphates; Iodine Radioisotopes; Kinetics; Migraine Disorders; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Time Factors; Treatment Outcome | 2003 |